Such changes can aid progression of disease and make patients more susceptible to respiratory tract infection.51-53 Therefore a DP2 antagonist might be useful in decreasing DP2 activation on epithelial cells and restoring normal epithelial differential processes. This evidence concerns the gene PTGDR2 and Respiratory tract infection.